Thyroid Neoplasm

last authored: April 2012, David LaPierre
last reviewed:

 

 

Introduction

Papillary carcinoma is the most common type of thyroid cancer and is showing the sharpest ↑ in incidence of all carcinomas in Canada. Its peak incidence is 30-40 years.

Cancer types, with worsening prognosis

  • pretty
  • follicular
  • hurthle
  • medullary
  • anaplastic

"Pretty females have men always"

Follicular carcinoma accounts for 15-20% of thyroid cancers, and is most common in people 40-50 years old. It is most prevalent in iodine-deficient areas.


Medullary carcinoma, occurring in 5-10% of thyroid malignancies, originates in parafollicular ‘C’ cells. Eighty percent are sporadic and the rest are familial (including MEN type II).

return to top

 

 

Causes and Risk Factors

Risk factors of malignancy in investigating a thyroid nodule include:

return to top

 

 

 

Pathophysiology

 

return to top

 

 

 

Signs and Symptoms

Typical presentation of Ca: asymptomatic thyroid nodule in euthyroid patient

  • history
  • physical exam

History

Cancer can often be asymptomatic. However, symptoms can incude:

  • pain
  • dysphagia
  • hoarseness

Physical Exam

The thyroid exam may show the following ominous signs:

  • hard consistency of the nodule
  • fixation of nodule to underlying tissues
  • lymphadenopathy

return to top

 

 

 

Investigations

  • lab investigations
  • diagnostic imaging

Lab Investigations

 

Investigations of a thyroid nodule begin with

  • TSH
  • T4 +/- T3

A fine needle aspiration (FNA) biopsy is a key step in diagnosis.

  • papillary: readily diagnosed
  • follicular: no cytologic diagnosis possible - need capsular or vascular invasion on resected specimen.

Elevated calcitonin levels may be present with medullary carcinoma.

Diagnostic Imaging

Ultrasound is one of the first imaging modalities.

 

Radiouptake scan: a cold gland suggests malignancy/

return to top

 

 

 

Treatments

Papillary carcinoma is treated by total thyroidectomy if a history of radiation is present, or thyroid lobectomy if not. Nodal excision is required if spread is detected.

 

, central LN dissection (level VI) + I-131.

Surveillance: serum thyroglobulin ± iodine scan

return to top

 

 

 

Consequences and Course

 

Papillary

Less than 5% of papillary cancers have metastasized at time of presentation.


Follicular

Rare LN mets: spreads hematogenously (lung, liver)

 

Medullary carcinoma is an aggressive form, with early LN mets. Rx: Total thyroidectomy + LN dissection + Radiation (external beam RT, not I-131). Surveillance: serum calcitonin.

 

Undifferentiated cancer has usually spread at time of presentation.

 

Risks for thyroid surgery include:

return to top

 

 

 

Additional Resources

 

 

return to top

 

Topic Development

authors:

reviewers:

 

 

return to top